Clinical impact of ganciclovir‐resistant cytomegalovirus infections in solid organ transplant patients

G Boivin, N Goyette, C Gilbert, A Humar… - Transplant infectious …, 2005 - Wiley Online Library
Clinical consequences of ganciclovir resistant cytomegalovirus (CMV) infections were
studied during 2 large prophylactic trials consisting of 100 days of valganciclovir or …

Clinical impact of ganciclovir-resistant cytomegalovirus infections in solid organ transplant patients.

G Boivin, N Goyette, C Gilbert, A Humar, E Covington - 2005 - cabidigitallibrary.org
Clinical consequences of ganciclovir resistant cytomegalovirus (CMV) infections were
studied during 2 large prophylactic trials consisting of 100 days of valganciclovir or …

Clinical impact of ganciclovir-resistant cytomegalovirus infections in solid organ transplant patients

G Boivin, N Goyette, C Gilbert… - … disease: an official …, 2005 - pubmed.ncbi.nlm.nih.gov
Clinical consequences of ganciclovir resistant cytomegalovirus (CMV) infections were
studied during 2 large prophylactic trials consisting of 100 days of valganciclovir or …

Clinical impact of ganciclovir-resistant cytomegalovirus infections in solid organ transplant patients.

G Boivin, N Goyette, C Gilbert, A Humar… - … Infectious Disease: an …, 2005 - europepmc.org
Clinical consequences of ganciclovir resistant cytomegalovirus (CMV) infections were
studied during 2 large prophylactic trials consisting of 100 days of valganciclovir or …

Clinical impact of ganciclovir-resistant cytomegalovirus infections in solid organ transplant patients.

G Boivin, N Goyette, C Gilbert… - Transplant …, 2005 - search.ebscohost.com
Clinical consequences of ganciclovir resistant cytomegalovirus (CMV) infections were
studied during 2 large prophylactic trials consisting of 100 days of valganciclovir or …

[引用][C] Clinical impact of ganciclovir-resistan cytomegalovirus infections in solid organ transplant patients

G BOIVIN, N GOYETTE, C GILBERT, A HUMAR… - Transplant infectious …, 2005 - Blackwell